Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Corticosteroids
1.2.3 Intravenous Immunoglobulin (IVIG)
1.2.4 Anti-D Immunoglobulin
1.2.5 Thrombopoietin Receptor Agonists (TPO-RA)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Perspective (2018-2034)
2.2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Growth Trends by Region
2.2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Region (2024-2034)
2.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Dynamics
2.3.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Trends
2.3.2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Drivers
2.3.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Challenges
2.3.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players by Revenue
3.1.1 Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue
3.4 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Concentration Ratio
3.4.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in 2024
3.5 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Key Players Head office and Area Served
3.6 Key Players Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Solution and Service
3.7 Date of Enter into Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Breakdown Data by Type
4.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Type (2024-2034)
5 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Breakdown Data by Application
5.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2034)
6.2 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023)
6.4 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2034)
7.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023)
7.4 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2034)
8.2 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2034)
9.2 Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2018-2034)
10.2 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roch
11.1.1 Roch Company Detail
11.1.2 Roch Business Overview
11.1.3 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.1.4 Roch Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
11.1.5 Roch Recent Development
11.2 Amgen Inc
11.2.1 Amgen Inc Company Detail
11.2.2 Amgen Inc Business Overview
11.2.3 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.2.4 Amgen Inc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
11.2.5 Amgen Inc Recent Development
11.3 Grifols Biologicals Inc.
11.3.1 Grifols Biologicals Inc. Company Detail
11.3.2 Grifols Biologicals Inc. Business Overview
11.3.3 Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.3.4 Grifols Biologicals Inc. Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
11.3.5 Grifols Biologicals Inc. Recent Development
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Detail
11.4.2 GlaxoSmithKline Plc Business Overview
11.4.3 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.4.4 GlaxoSmithKline Plc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
11.4.5 GlaxoSmithKline Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Intravenous Immunoglobulin (IVIG)
Table 4. Key Players of Anti-D Immunoglobulin
Table 5. Key Players of Thrombopoietin Receptor Agonists (TPO-RA)
Table 6. Key Players of Others
Table 7. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 9. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2018-2023)
Table 11. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 12. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2024-2034)
Table 13. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Trends
Table 14. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Drivers
Table 15. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Challenges
Table 16. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Restraints
Table 17. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Players (2018-2023)
Table 19. Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics as of 2024)
Table 20. Ranking of Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product Solution and Service
Table 24. Date of Enter into Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Type (2024-2034)
Table 30. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Application (2018-2023)
Table 32. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Application (2024-2034)
Table 34. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 37. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 40. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 41. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2024-2034) & (US$ Million)
Table 43. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 46. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 47. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 49. Roch Company Detail
Table 50. Roch Business Overview
Table 51. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
Table 52. Roch Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023) & (US$ Million)
Table 53. Roch Recent Development
Table 54. Amgen Inc Company Detail
Table 55. Amgen Inc Business Overview
Table 56. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
Table 57. Amgen Inc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023) & (US$ Million)
Table 58. Amgen Inc Recent Development
Table 59. Grifols Biologicals Inc. Company Detail
Table 60. Grifols Biologicals Inc. Business Overview
Table 61. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
Table 62. Grifols Biologicals Inc. Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023) & (US$ Million)
Table 63. Grifols Biologicals Inc. Recent Development
Table 64. GlaxoSmithKline Plc Company Detail
Table 65. GlaxoSmithKline Plc Business Overview
Table 66. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
Table 67. GlaxoSmithKline Plc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023) & (US$ Million)
Table 68. GlaxoSmithKline Plc Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type: 2024 VS 2034
Figure 3. Corticosteroids Features
Figure 4. Intravenous Immunoglobulin (IVIG) Features
Figure 5. Anti-D Immunoglobulin Features
Figure 6. Thrombopoietin Receptor Agonists (TPO-RA) Features
Figure 7. Others Features
Figure 8. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application: 2024 VS 2034
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Report Years Considered
Figure 14. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region: 2024 VS 2034
Figure 17. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Players in 2024
Figure 18. Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in 2024
Figure 20. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2018-2034)
Figure 22. United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2018-2034)
Figure 26. Germany Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2018-2034)
Figure 34. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Southeast Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Australia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2018-2034)
Figure 42. Mexico Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Brazil Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2018-2034)
Figure 46. Turkey Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Saudi Arabia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Roch Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
Figure 49. Amgen Inc Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
Figure 50. Grifols Biologicals Inc. Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
Figure 51. GlaxoSmithKline Plc Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed